A detailed history of Russell Investments Group, Ltd. transactions in Biolife Solutions Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 442,228 shares of BLFS stock, worth $9.57 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
442,228
Previous 363,998 21.49%
Holding current value
$9.57 Million
Previous $7.8 Million 41.9%
% of portfolio
0.02%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$19.19 - $26.52 $1.5 Million - $2.07 Million
78,230 Added 21.49%
442,228 $11.1 Million
Q2 2024

Aug 08, 2024

BUY
$15.14 - $22.99 $2.57 Million - $3.91 Million
169,872 Added 87.51%
363,998 $7.8 Million
Q1 2024

May 08, 2024

BUY
$15.35 - $18.82 $170,016 - $208,450
11,076 Added 6.05%
194,126 $3.6 Million
Q4 2023

Feb 05, 2024

SELL
$8.99 - $16.86 $17,917 - $33,601
-1,993 Reduced 1.08%
183,050 $2.97 Million
Q3 2023

Nov 13, 2023

SELL
$10.81 - $22.96 $513,366 - $1.09 Million
-47,490 Reduced 20.42%
185,043 $2.56 Million
Q2 2023

Aug 10, 2023

BUY
$17.19 - $24.34 $263,350 - $372,888
15,320 Added 7.05%
232,533 $5.14 Million
Q1 2023

May 09, 2023

SELL
$17.67 - $26.07 $142,579 - $210,358
-8,069 Reduced 3.58%
217,213 $4.72 Million
Q4 2022

Feb 08, 2023

SELL
$16.95 - $25.07 $204,518 - $302,494
-12,066 Reduced 5.08%
225,282 $4.1 Million
Q3 2022

Nov 04, 2022

BUY
$14.64 - $26.7 $221,927 - $404,745
15,159 Added 6.82%
237,348 $5.4 Million
Q2 2022

Jul 29, 2022

SELL
$10.54 - $24.2 $2.44 Million - $5.6 Million
-231,568 Reduced 51.03%
222,189 $3.07 Million
Q1 2022

May 05, 2022

SELL
$20.81 - $37.29 $1.23 Million - $2.2 Million
-59,114 Reduced 11.53%
453,757 $10.3 Million
Q4 2021

Jan 21, 2022

BUY
$32.99 - $58.55 $3.55 Million - $6.3 Million
107,584 Added 26.55%
512,871 $19.1 Million
Q3 2021

Nov 08, 2021

SELL
$42.03 - $60.5 $3.08 Million - $4.43 Million
-73,184 Reduced 15.3%
405,287 $17.1 Million
Q2 2021

Aug 04, 2021

SELL
$29.51 - $44.62 $5.1 Million - $7.71 Million
-172,778 Reduced 26.53%
478,471 $21.3 Million
Q1 2021

May 10, 2021

SELL
$32.95 - $44.24 $6.24 Million - $8.38 Million
-189,390 Reduced 22.53%
651,249 $23.4 Million
Q4 2020

Feb 08, 2021

SELL
$27.5 - $45.75 $1.43 Million - $2.37 Million
-51,849 Reduced 5.81%
840,639 $33.6 Million
Q3 2020

Nov 09, 2020

BUY
$16.04 - $28.94 $3.5 Million - $6.32 Million
218,316 Added 32.38%
892,488 $25.8 Million
Q2 2020

Aug 05, 2020

BUY
$9.2 - $17.06 $2.35 Million - $4.35 Million
255,139 Added 60.89%
674,172 $11 Million
Q1 2020

May 06, 2020

SELL
$8.36 - $17.03 $1.14 Million - $2.32 Million
-136,506 Reduced 24.57%
419,033 $3.98 Million
Q4 2019

Jan 29, 2020

SELL
$14.59 - $18.9 $398,365 - $516,045
-27,304 Reduced 4.68%
555,539 $8.99 Million
Q3 2019

Nov 01, 2019

BUY
$15.7 - $20.98 $4.45 Million - $5.95 Million
283,603 Added 94.77%
582,843 $9.69 Million
Q2 2019

Aug 09, 2019

BUY
$15.2 - $19.42 $3.17 Million - $4.05 Million
208,786 Added 230.82%
299,240 $5.07 Million
Q1 2019

May 13, 2019

BUY
$10.9 - $21.26 $985,948 - $1.92 Million
90,454 New
90,454 $1.62 Million

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $924M
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.